Key result
Laboratory markers, including BNP and pro-BNP, offer potential clinical and prognostic value for identifying high-risk patients with acute coronary syndromes.
Why the study?
Do novel laboratory markers provide incremental prognostic information in patients with acute coronary syndromes?
Do novel laboratory markers provide incremental prognostic information in patients with acute coronary syndromes?
This review highlights the potential of various novel laboratory markers to provide incremental prognostic value beyond traditional markers in patients with acute coronary syndromes.
May support ACS risk stratification; leaves open whether novel markers add incremental value beyond traditional ones.
Summary A number of “interesting” risk markers have been proposed as providing prognostic informations in acute coronary syndromes (ACS). Elevation in plasma inflammatory and necrosis biomarkers have been related to future cardiovascular events in individuals with or without prior myocardial infarction. Recently BNP and pro-BNP are entered in clinical practice to recognize patients at major risk, providing incremental information respect to the traditional markers. Together with these laboratory indexes, a few of promising laboratory markers once easily available, could become usefull in identification of patients at high risk. Several studies evaluated many markers of platelet aggregation, endothelial dysfunction and vascular thrombosis, but it is not yet clear whether each of the proposed markers may provide incremental predictive information. We describe, following the most studies reported in literature, the laboratory markers with potential clinical and prognostic power that could early help physicians in the identification of patients with impaired coronary disease and more narrowed coronary arteries.
No takes yet. Share an insight, caveat, or question.
Palazzuoli et al. (2006) conducted a review in Acute coronary syndromes. Laboratory markers was evaluated. Laboratory markers, including BNP and pro-BNP, offer potential clinical and prognostic value for identifying high-risk patients with acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: